{"id":49113,"date":"2022-10-04T09:01:47","date_gmt":"2022-10-04T07:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/"},"modified":"2022-10-04T09:01:47","modified_gmt":"2022-10-04T07:01:47","slug":"dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/","title":{"rendered":"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now<\/i>\n<\/li>\n<li>\n<i>The new CGM system is also expected to launch in New Zealand and South Africa in the weeks ahead, with additional markets planned soon after<\/i>\n<\/li>\n<li>\n<i>A global, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcomevent.com%2F&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=streaming+launch+event&amp;index=1&amp;md5=7897fee8d3a63120a56fee7f53ee8696\" rel=\"nofollow noopener\" shape=\"rect\">streaming launch event<\/a> held today revealed an inside look at Dexcom G7 through the eyes of company leadership, the G7 project team and Dexcom Warriors from around the world<\/i>\n<\/li>\n<li>\n<i>Dexcom G7 has the fastest sensor warmup on the market,* with no finger sticks<sup>\u2020<\/sup>\u00a0or scanning required, and builds on the unparalleled accuracy of Dexcom CGM<sup>1<\/sup> that is supported by more peer reviewed, clinical research than any other CGM<\/i>\n<\/li>\n<\/ul>\n<p>SAN DIEGO &amp; EDINBURGH, Scotland&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24DXCM&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$DXCM<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/CGM?src=hash\" target=\"_blank\" rel=\"noopener\">#CGM<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcom.com%2F&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=DexCom%2C+Inc.&amp;index=2&amp;md5=2c868e4e2c5878d17c4ba0524864012f\" rel=\"nofollow noopener\" shape=\"rect\">DexCom, Inc.<\/a> (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available for people with diabetes age two years and older in the UK, Ireland, Germany, Austria and Hong Kong \u2013 marking the first major milestone in the availability of the revolutionary new technology. The company is also working quickly to introduce G7 in New Zealand and South Africa in the weeks ahead, with additional markets planned soon after.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/5\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1474219\/4\/New_Dexcom_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1474219\/21\/New_Dexcom_Logo.jpg\"><\/a><\/p>\n<p>\n\u201cSince Dexcom G6 came to market, we\u2019ve eliminated over 15 billion fingerpricks<sup>\u2021<\/sup> and helped improve the lives of more than 1.25 million people with diabetes around the world. We\u2019re thrilled to begin the global rollout of Dexcom G7, our next-generation CGM technology, that vastly improves upon what everyone loves about G6,\u201d said Kevin Sayer, chairman, president and CEO of Dexcom. \u201cDexcom CGM has become the gold standard of care for diabetes, and bringing our technology to more and more people around the world continues to be a top priority. With this initial launch behind us, we look forward to introducing G7 in additional markets and bringing this life-changing technology to as many people as we can.\u201d\n<\/p>\n<p>\nTo introduce the highly anticipated new device, earlier today Dexcom hosted a global <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcomevent.com%2F&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=streaming+launch+event&amp;index=3&amp;md5=42d1178d898f42c4cb623355af04497d\" rel=\"nofollow noopener\" shape=\"rect\">streaming launch event<\/a> that delivered a behind-the-scenes look at the making of G7 and featured first-hand accounts from Dexcom Warriors from around the world discussing how Dexcom CGM has changed their lives.\n<\/p>\n<p>\n\u201cThere were so many times, especially when Ava was first diagnosed, that our lives had to fit around the disease, and not the other way around,\u201d said Rebecca Ridgeway, mother to six-year-old Ava, a budding gymnast managing Type 1 diabetes in the UK who was featured during the streaming event. \u201cWhen we got Dexcom CGM, we felt like we\u2019d finally been given a tool that gave us more control. It was lifechanging for us when Ava started using Dexcom, and Dexcom G7 brings it to a whole new level.\u201d\n<\/p>\n<p>\nThe event also included comments from Dexcom leadership and key members of the G7 project team \u2013 Kevin Sayer, CEO; Jake Leach, COO; Anne Santoro, VP, global customer experience; Apurv Kamath, senior VP, product, global marketing; and Alex Diener, senior director, global product design.\n<\/p>\n<p>\n\u201cDexcom customers from around the world were a part of the G7 design process,\u201d said Diener, who helped design G7 and lives with Type 1 diabetes. \u201cWe learned from people living with Type 1 and Type 2 diabetes, younger and older patients, and their caregivers, about the CGM features they need to allow them to focus more on their everyday lives and less on managing diabetes.\u201d\n<\/p>\n<p>\nThe streaming launch event can be viewed on demand at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcomevent.com%2F&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=DexcomEvent.com&amp;index=4&amp;md5=33ecc641345ac8244fc9be3fcd3938da\" rel=\"nofollow noopener\" shape=\"rect\">DexcomEvent.com<\/a>.\n<\/p>\n<p>\n<b>Dexcom G7: The Most Powerful CGM on the Market<\/b>\n<\/p>\n<p>\nDexcom G7 offers a powerful yet simple way to help users gain greater control of their diabetes, so they can manage the disease more confidently each day. Its low-profile, all-in-one wearable warms up faster than any other CGM on the market,<sup>*<\/sup> sending real-time glucose readings automatically to a compatible smart device<i><sup>\u00a7<\/sup><\/i> or receiver, no painful finger sticks<sup>\u2020<\/sup> or burdensome scanning required.\n<\/p>\n<p>\nDexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C and reduce hyper- and hypoglycemia.<sup>||,1 <\/sup>Its customizable alerts can warn of high or low glucose levels and help users spend more time in range.<sup>||,2<\/sup> Industry-leading remote monitoring and reporting capabilities also allow users to stay connected with their loved ones and care teams anytime, anywhere.<sup>\u00b6<\/sup>\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<b>New features with Dexcom G7:<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n60 percent smaller, all-in-one, discreet wearable, developed in partnership with Verily\n<\/li>\n<li>\n30-minute sensor warm up, fastest of any CGM on the market<sup>*<\/sup>\n<\/li>\n<li>\n12-hour grace period to replace finished sensors for a more seamless transition between sessions\n<\/li>\n<li>\nRedesigned and simplified mobile app with Dexcom Clarity integration<sup>#,**<\/sup>\n<\/li>\n<li>\nImproved alert settings for enhanced discretion\n<\/li>\n<li>\nRedesigned optional receiver that is smaller, with a more vibrant, easier to read display\n<\/li>\n<li>\nDirect to Apple Watch (anticipated future software release)\n<\/li>\n<\/ul>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<b>Dexcom G6 features included with Dexcom G7:<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nNo finger sticks<sup>\u2020<\/sup>, scanning or calibration\n<\/li>\n<li>\nReal-time glucose readings sent automatically to a compatible display device<i><sup>\u00a7<\/sup><\/i>\n<\/li>\n<li>\nIndicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old\n<\/li>\n<li>\nIntegration with the world\u2019s largest connected CGM ecosystem\n<\/li>\n<li>\nRemote monitoring, enabling users to share glucose data with up to 10 followers<sup>\u00b6<\/sup>\n<\/li>\n<li>\nProven Dexcom accuracy and performance<sup>3<\/sup><\/p>\n<p>\n\u00a0\n<\/p>\n<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nDexcom is also working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as possible.\n<\/p>\n<p>\nTo learn more about Dexcom G7 visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcomevent.com%2F&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=DexcomEvent.com&amp;index=5&amp;md5=4a26600118bdb0cb159dc2b172e8a2d2\" rel=\"nofollow noopener\" shape=\"rect\">DexcomEvent.com<\/a>. For further details on Dexcom CGM, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcom.com%2F&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=Dexcom.com&amp;index=6&amp;md5=f43ba6853064765dcb0b8b7036d97910\" rel=\"nofollow noopener\" shape=\"rect\">Dexcom.com<\/a>.\n<\/p>\n<p>\nDexcom submitted a comprehensive 510(k) pre-market notification to the U.S. Food and Drug Administration for regulatory review of the Dexcom G7 CGM System in accordance with the iCGM Special Controls in Q4 2021.<sup>\u2020\u2020<\/sup>\n<\/p>\n<p>\n<b><span class=\"bwuline\">About DexCom, Inc.<\/span><\/b>\n<\/p>\n<p>\nDexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia\/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcom.com&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=www.dexcom.com&amp;index=7&amp;md5=6aef0d02fc53c2bf1e4bae11ac8213e4\" rel=\"nofollow noopener\" shape=\"rect\">www.dexcom.com<\/a>.\n<\/p>\n<p>\n<i><sup>*<\/sup>Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.<br \/>\n<br \/><\/i><i><sup>\u2020<\/sup>If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.<br \/>\n<br \/><\/i><sup>\u2021<\/sup><i>Dexcom, data on file.<br \/>\n<br \/><\/i><i><sup>\u00a7<\/sup>To view a list of compatible smart devices, visit <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcom.com%2Fcompatibility&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=dexcom.com%2Fcompatibility&amp;index=8&amp;md5=fffb00872538d317569580bbd367c76a\" rel=\"nofollow noopener\" shape=\"rect\"><i>dexcom.com\/compatibility<\/i><\/a><i><br \/><\/i><i><sup>||<\/sup>Results obtained with a prior generation Dexcom CGM System.<br \/>\n<br \/><\/i><sup>\u00b6<\/sup><i>Separate Dexcom Follow app and internet connection required. Internet connectivity required for data sharing. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.<br \/>\n<br \/><\/i><i><sup>#<\/sup>Healthcare providers can register for Dexcom Clarity at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fclarity.dexcom.com%2Fprofessional%2Fregistration&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=clarity.dexcom.com%2Fprofessional%2Fregistration&amp;index=9&amp;md5=936a334a2a3a13c4781977a1606b5916\" rel=\"nofollow noopener\" shape=\"rect\">clarity.dexcom.com\/professional\/registration<\/a>.<br \/>\n<br \/><\/i><i><sup>**<\/sup>An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fdexcom.com%2Fcompatibility&amp;esheet=52935480&amp;newsitemid=20221004005386&amp;lan=en-US&amp;anchor=dexcom.com%2Fcompatibility&amp;index=10&amp;md5=e0ca5ab7536beb02377eb0bc764edab0\" rel=\"nofollow noopener\" shape=\"rect\"><i>dexcom.com\/compatibility<\/i><\/a><i>. Healthcare providers will only be able to view a patient\u2019s glucose data if the patient elects to share it with them through Dexcom Clarity.<br \/>\n<br \/><\/i><i><sup>\u2020\u2020<\/sup>Pending 510(k) clearance &#8212; Not available for sale in the U.S.<\/i>\n<\/p>\n<p>\n<i><sup>1 <\/sup>Beck RW, et al. JAMA. 2017;317(4):371-378.<br \/>\n<br \/><\/i><i><sup>2 <\/sup>Welsh JB, et al. Diabetes Technol Ther. 2019;21(3):128-132.<br \/>\n<br \/><\/i><i><sup>3<\/sup><\/i><i> Dexcom G7 User Guide.<\/i>\n<\/p>\n<p>\n<i>\u00a9 2022 Dexcom, Inc. Dexcom, Dexcom G6, Dexcom G7 and Dexcom Clarity are registered trademarks of DexCom, Inc. in the U.S., and may be registered in other countries. All rights reserved.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b><span class=\"bwuline\">Media Contact<\/span><\/b><br \/>James McIntosh<br \/>\n<br \/>619-884-2118<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x6a;&#x61;&#x6d;&#101;&#115;&#46;m&#x63;&#x69;&#x6e;&#116;&#111;sh&#x40;&#x64;&#x65;&#120;&#99;om&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">j&#97;&#x6d;&#x65;s&#46;&#109;&#x63;&#x69;n&#116;&#x6f;&#x73;h&#64;&#100;&#x65;&#x78;c&#111;&#x6d;&#x2e;c&#111;&#109;<\/a>\n<\/p>\n<p>\n<b><span class=\"bwuline\">Investor Contact<\/span><\/b><br \/>Sean Christensen<br \/>\n<br \/>858-203-6657<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#115;ean&#x2e;&#x63;&#x68;&#x72;&#x69;&#115;&#116;&#101;nse&#x6e;&#x40;&#x64;&#x65;&#x78;&#99;&#111;&#109;&#46;co&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#115;&#x65;&#97;&#x6e;&#46;&#99;&#x68;&#114;&#x69;s&#x74;e&#110;&#x73;&#101;&#x6e;&#64;&#x64;&#x65;&#120;&#x63;o&#x6d;&#46;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in New Zealand and South Africa in the weeks ahead, with additional markets planned soon after A global, streaming launch event held today revealed an inside &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49113","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in New Zealand and South Africa in the weeks ahead, with additional markets planned soon after A global, streaming launch event held today revealed an inside ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T07:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System\",\"datePublished\":\"2022-10-04T07:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/\"},\"wordCount\":1279,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005386\\\/en\\\/1590795\\\/21\\\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/\",\"name\":\"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005386\\\/en\\\/1590795\\\/21\\\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\",\"datePublished\":\"2022-10-04T07:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005386\\\/en\\\/1590795\\\/21\\\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005386\\\/en\\\/1590795\\\/21\\\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/","og_locale":"en_US","og_type":"article","og_title":"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System - Pharma Trend","og_description":"People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in New Zealand and South Africa in the weeks ahead, with additional markets planned soon after A global, streaming launch event held today revealed an inside ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-04T07:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System","datePublished":"2022-10-04T07:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/"},"wordCount":1279,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/","url":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/","name":"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg","datePublished":"2022-10-04T07:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221004005386\/en\/1590795\/21\/Chef_Wearing_Dexcom_G7%5B1%5D.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dexcom-g7-launches-in-the-united-kingdom-ireland-germany-austria-and-hong-kong-initiating-global-rollout-of-worlds-most-powerful-continuous-glucose-monitoring-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong \u2013 Initiating Global Rollout of World\u2019s Most Powerful Continuous Glucose Monitoring System"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49113"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49113\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}